GT199900156A - Administraciòn de agente activo en polvo seco. - Google Patents

Administraciòn de agente activo en polvo seco.

Info

Publication number: GT199900156A
Authority: GT; Guatemala
Prior art keywords: active agent; dry powder; administration; hygroscopic; development
Prior art date: 1998-09-14

Application number

GT199900156A

Other languages

English (en)

Spanish (es)

Inventor

Andrew Clark

Mei Chang Kuo

Cecily Lalor

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-14

Filing date

1999-09-14

Publication date

2001-03-07

1999-09-14 Application filed filed Critical

2001-03-07 Publication of GT199900156A publication Critical patent/GT199900156A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)

GT199900156A 1998-09-14 1999-09-14 Administraciòn de agente activo en polvo seco. GT199900156A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10016398P	1998-09-14	1998-09-14

Publications (1)

Publication Number	Publication Date
GT199900156A true GT199900156A (es)	2001-03-07

Family

ID=22278404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GT199900156A GT199900156A (es)	1998-09-14	1999-09-14	Administraciòn de agente activo en polvo seco.

Country Status (44)

Country	Link
EP (1)	EP1117442A1 (fr)
JP (1)	JP2002524535A (fr)
KR (1)	KR20010075063A (fr)
CN (1)	CN1317977A (fr)
AP (1)	AP1374A (fr)
AR (1)	AR022090A1 (fr)
AU (1)	AU753014B2 (fr)
BG (1)	BG105430A (fr)
BR (1)	BR9913722A (fr)
CA (1)	CA2343920A1 (fr)
CO (1)	CO5130023A1 (fr)
CZ (1)	CZ2001829A3 (fr)
DZ (1)	DZ2892A1 (fr)
EA (1)	EA003476B1 (fr)
EE (1)	EE200100151A (fr)
GE (1)	GEP20043257B (fr)
GT (1)	GT199900156A (fr)
HK (1)	HK1042231A1 (fr)
HN (1)	HN1999000159A (fr)
HR (1)	HRP20010189A2 (fr)
HU (1)	HUP0103837A3 (fr)
ID (1)	ID28845A (fr)
IL (2)	IL141562A0 (fr)
IS (1)	IS5878A (fr)
LT (1)	LT4897B (fr)
LV (1)	LV12658B (fr)
MA (1)	MA25590A1 (fr)
MY (1)	MY129282A (fr)
NO (1)	NO20011251L (fr)
NZ (1)	NZ510168A (fr)
OA (1)	OA11781A (fr)
PA (1)	PA8481901A1 (fr)
PE (1)	PE20001061A1 (fr)
PL (1)	PL195574B1 (fr)
SA (1)	SA99200718B1 (fr)
SK (1)	SK3442001A3 (fr)
TN (1)	TNSN99173A1 (fr)
TR (1)	TR200101182T2 (fr)
TW (1)	TWI226248B (fr)
UA (1)	UA76085C2 (fr)
UY (1)	UY25711A1 (fr)
WO (1)	WO2000015262A1 (fr)
YU (1)	YU24201A (fr)
ZA (1)	ZA200101995B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6956021B1 (en)	1998-08-25	2005-10-18	Advanced Inhalation Research, Inc.	Stable spray-dried protein formulations
WO2000075281A2 (fr)	1999-06-09	2000-12-14	University Technology Corporation	Nebulisation et sechage de bulles assiste par un fluide supercritique
US6475468B2 (en) *	2001-02-15	2002-11-05	Aeropharm Technology Incorporated	Modulated release particles for aerosol delivery
EP1392262A1 (fr) *	2001-05-24	2004-03-03	Alexza Molecular Delivery Corporation	Administration d'esters medicamenteux par inhalation
EG24184A (en)	2001-06-15	2008-10-08	Otsuka Pharma Co Ltd	Dry powder inhalation system for transpulmonary
JP4368198B2 (ja)	2001-11-20	2009-11-18	アルカーメス，インコーポレイテッド	肺送達用の改良された粒状組成物
US7759506B2 (en)	2002-02-25	2010-07-20	Diffusion Pharmaceuticals Llc	Bipolar trans carotenoid salts and their uses
EA200401111A1 (ru)	2002-02-25	2005-02-24	Диффьюжн Фармасьютикалз Ллс	Биполярные соли транс-каротиноидов и их применение
WO2004004798A2 (fr) *	2002-07-03	2004-01-15	The Brigham And Women's Hospital, Inc.	Introduction par les voies aeriennes centrales pour l'administration systemique d'agents therapeutiques
ATE353633T1 (de) *	2002-12-19	2007-03-15	Pharmacia Corp	Nicht-hygroskopische formulierung, die einen hygroskopischen wirkstoff enthält
DE10338403A1 (de) *	2003-08-18	2005-03-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) *	2003-09-15	2003-12-31	Vectura Ltd	Pharmaceutical compositions
US20070020299A1 (en)	2003-12-31	2007-01-25	Pipkin James D	Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CN101098678A (zh)	2004-04-23	2008-01-02	锡德克斯公司	含有磺基烷基醚环糊精的dpi制剂
MX2007010359A (es)	2005-02-24	2008-04-04	Diffusion Pharmaceuticals Llc	Trans carotenoides, su sintesis, formulacion y usos.
JPWO2006095788A1 (ja) *	2005-03-09	2008-08-14	小野薬品工業株式会社	粒子およびその粒子を含有する製剤
PL2952197T3 (pl)	2005-10-26	2017-09-29	Cydex Pharmaceuticals, Inc.	Kompozycje eteru sulfoalkilowego cyklodekstryny i sposoby ich wytwarzania
US7629331B2 (en)	2005-10-26	2009-12-08	Cydex Pharmaceuticals, Inc.	Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20100269819A1 (en) *	2006-08-14	2010-10-28	Sievers Robert E	Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
US20100093875A1 (en) *	2006-10-25	2010-04-15	Dainippon Sumitomo Pharma Co., Ltd.	Granular preparation prevented from caking
EP1925295A1 (fr) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Formule de poudre stable contenant un nouveau anticholinergique
CA2683760C (fr)	2007-04-13	2015-05-19	Diffusion Pharmaceuticals Llc	Utilisation de transcarotenoides bipolaires en tant que traitement prealable et dans le traitement de pathologies vasculaires peripheriques
US12370352B2 (en)	2007-06-28	2025-07-29	Cydex Pharmaceuticals, Inc.	Nasal and ophthalmic delivery of aqueous corticosteroid solutions
US8206751B2 (en)	2007-10-31	2012-06-26	Diffusion Pharmaceuticals Llc	Class of therapeutics that enhance small molecule diffusion
CN105770882A (zh)	2009-05-20	2016-07-20	Aeras全球Tb疫苗基金会	稳定的经喷雾干燥的免疫原性的病毒组合物
US10130689B2 (en)	2009-06-22	2018-11-20	Diffusion Pharmaceuticals Llc	Diffusion enhancing compounds and their use alone or with thrombolytics
WO2011152869A1 (fr)	2010-06-02	2011-12-08	Diffusion Pharmaceuticals Llc	Formes pharmaceutiques orales à base de caroténoïdes trans bipolaires
CA2866230C (fr)	2012-05-03	2020-08-18	Janssen R&D Ireland	Formulations d'acide polyinosinique-polycytidylique (poly (i:c)) pour le traitement d'infections du tractus respiratoire superieur
BR112015010601B1 (pt) *	2012-11-09	2022-07-19	Civitas Therapeutics, Inc.	Composição farmacêutica e uso da composição
WO2015042352A1 (fr) *	2013-09-20	2015-03-26	Virginia Commonwealth University	Administration de particules à l'aide d'excipients hygroscopiques
CA2965759C (fr)	2014-10-31	2023-12-12	Glaxosmithkline Intellectual Property Development Limited	Polypeptides en poudre presentant moins d'impuretes de disulfide comprenant des materiaux cationiques divalents
CN109152839A (zh)	2016-03-24	2019-01-04	扩散药品有限公司	双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途
US20220378727A1 (en) *	2021-05-14	2022-12-01	The University Of Hong Kong	Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3155573A (en) *	1958-05-06	1964-11-03	Benger Lab Ltd	Inhalant composition and method of making same
CA2115065C (fr) *	1992-06-12	2000-10-03	Kiyoyuki Sakon	Poudre particulaire ultrafine pour inhalation et methode de production
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
US5874064A (en)	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery
EP0954282B1 (fr) *	1997-01-16	2005-01-19	Massachusetts Institute Of Technology	Preparation de particules pour inhalation
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

1999
- 1999-09-09 MA MA25762A patent/MA25590A1/fr unknown
- 1999-09-13 YU YU24201A patent/YU24201A/sh unknown
- 1999-09-13 PL PL99346768A patent/PL195574B1/pl not_active IP Right Cessation
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 CN CN99810871A patent/CN1317977A/zh active Pending
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/fr not_active Ceased
- 1999-09-13 HR HR20010189A patent/HRP20010189A2/hr not_active Application Discontinuation
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 HK HK02101738.3A patent/HK1042231A1/zh unknown
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/xx unknown
- 1999-09-13 ID IDW20010582A patent/ID28845A/id unknown
- 1999-09-13 CA CA002343920A patent/CA2343920A1/fr not_active Abandoned
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/ko not_active Ceased
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/sk unknown
- 1999-09-13 AR ARP990104587A patent/AR022090A1/es unknown
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/hu unknown
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/es not_active Application Discontinuation
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 EA EA200100300A patent/EA003476B1/ru active IP Right Revival
- 1999-09-13 EE EEP200100151A patent/EE200100151A/xx unknown
- 1999-09-13 IL IL14156299A patent/IL141562A0/xx not_active IP Right Cessation
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/es unknown
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 UA UA2001031707A patent/UA76085C2/uk unknown
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/cs unknown
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/pt not_active IP Right Cessation
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 EP EP99969035A patent/EP1117442A1/fr not_active Withdrawn
- 1999-09-13 TW TW088115876A patent/TWI226248B/zh not_active IP Right Cessation
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/fr active
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/ja not_active Withdrawn
- 1999-09-14 CO CO99058265A patent/CO5130023A1/es unknown
- 1999-09-14 GT GT199900156A patent/GT199900156A/es unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/fr unknown
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/es unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/es not_active Application Discontinuation
- 1999-10-31 SA SA99200718A patent/SA99200718B1/ar unknown
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/is unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/no not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/lt not_active IP Right Cessation
- 2001-03-14 LV LV010041A patent/LV12658B/xx unknown
- 2001-04-10 BG BG105430A patent/BG105430A/xx unknown

Also Published As

Publication number	Publication date
NO20011251L (no)	2001-04-17
TR200101182T2 (tr)	2001-09-21
TNSN99173A1 (fr)	2005-11-10
AR022090A1 (es)	2002-09-04
ID28845A (id)	2001-07-05
EE200100151A (et)	2002-06-17
HUP0103837A2 (hu)	2002-05-29
HRP20010189A2 (en)	2005-04-30
TWI226248B (en)	2005-01-11
CN1317977A (zh)	2001-10-17
SK3442001A3 (en)	2001-11-06
SA99200718B1 (ar)	2006-11-04
PL195574B1 (pl)	2007-10-31
CA2343920A1 (fr)	2000-03-23
JP2002524535A (ja)	2002-08-06
HK1042231A1 (zh)	2002-08-09
EA003476B1 (ru)	2003-06-26
PL346768A1 (en)	2002-02-25
EP1117442A1 (fr)	2001-07-25
IL141562A0 (en)	2002-03-10
BR9913722A (pt)	2001-05-29
CZ2001829A3 (cs)	2001-09-12
NZ510168A (en)	2003-09-26
AP1374A (en)	2005-02-28
MA25590A1 (fr)	2002-12-31
OA11781A (en)	2005-07-26
HUP0103837A3 (en)	2002-11-28
AU6039799A (en)	2000-04-03
UA76085C2 (en)	2006-07-17
AU753014B2 (en)	2002-10-03
LV12658B (lv)	2001-09-20
CO5130023A1 (es)	2002-02-27
IS5878A (is)	2001-03-05
NO20011251D0 (no)	2001-03-13
MY129282A (en)	2007-03-30
PE20001061A1 (es)	2000-10-08
UY25711A1 (es)	1999-11-17
AP2001002093A0 (en)	2001-03-31
PA8481901A1 (es)	2002-04-25
DZ2892A1 (fr)	2003-12-15
EA200100300A1 (ru)	2001-10-22
GEP20043257B (en)	2004-06-25
BG105430A (en)	2001-12-29
LT4897B (lt)	2002-02-25
LV12658A (lv)	2001-05-20
IL141562A (en)	2007-07-24
WO2000015262A1 (fr)	2000-03-23
KR20010075063A (ko)	2001-08-09
LT2001021A (en)	2001-11-26
HN1999000159A (es)	1999-11-11
YU24201A (sh)	2003-08-29
ZA200101995B (en)	2002-03-11

Publication	Publication Date	Title
GT199900156A (es)	2001-03-07	Administraciòn de agente activo en polvo seco.
DK1318788T3 (da)	2008-04-14	Nanopartikulær fastdosissammensætninger
CY1110376T1 (el)	2015-04-29	Χρηση μιας συνθεσης που περιλαμβανει φορμοτερολη και βουδεσονιδη για την προληψη απο ή τη θεραπευτικη αντιμετωπιση μιας οξειας καταστασης ασθματος
BR0212950A (pt)	2004-10-26	Formas de dosagens compósitas tendo uma porção inserida
TR200101033T2 (tr)	2001-11-21	Akış direnci hafifletilmiş, aerosol halindeki aktif maddenin verilmesi
HRP20030993B1 (en)	2011-10-31	Inhalation capsules
CO5060522A1 (es)	2001-07-30	Administracion de un agente activo en aerosol
NO20040917L (no)	2004-03-02	Oftamologiske depotpreparater for periokular eller subkonjunktival administrering.
SE8202172L (sv)	1982-10-07	Topiska farmaceutiska kompositioner
PT1061979E (pt)	2005-02-28	Inalador do po
BRPI0408655A (pt)	2006-03-28	formulações compreendendo um agente ativo e cacau em pó e a sua utilização
DE60024317D1 (de)	2005-12-29	Korrektor für schuh
BR0012444A (pt)	2002-04-02	Composições de pó seco
HRP20050510A2 (en)	2006-06-30	Microbicide substances
NO331082B1 (no)	2011-10-03	Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft
DK0930077T3 (da)	2003-08-04	Cyclodextrinpræparater indeholdende et avermectin- eller milbemycinderivat
HRP20050342B1 (hr)	2013-11-08	Farmaceutska formulacija olanzapina
DE69933671D1 (de)	2006-11-30	Adenosin a1 antagonisten gegen männliche sterilität
DE69331007D1 (de)	2001-11-29	Difluoroavermectin-derivate
BR0012775A (pt)	2002-04-02	Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido
ES2170070T3 (es)	2002-08-01	Composiciones de mezclas secas de eteres de celulosa, libres de azucar, como laxantes que aumentan el volumen de las heces.
BR0208865A (pt)	2004-10-19	Aplicador para aplicação de agente benéfico sobre os dentes e uso de um aplicador
UY27306A1 (es)	2002-12-31	Cápsulas elásticas blandas y composiciones de las mismas
BRPI0412706A (pt)	2006-09-26	composição farmacêutica orodispersìvel de um composto antitrombótico
DK1735013T3 (da)	2012-05-21	Alfa- og beta-udsendende hydroxyapatitpartikler